Bryson W. Katona, MD, PhD

faculty photo
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Director, Gastrointestinal Cancer Genetics Program, Penn Medicine
Director, Gastrointestinal Cancer Risk Evaluation Program, Penn Medicine
Director, Lynch Syndrome Program, Penn Medicine
Member, Abramson Cancer Center - Cancer Control Program
Member, Institute for Translational Medicine and Therapeutics
Department: Medicine
Graduate Group Affiliations

Contact information
751 Perelman Center for Advanced Medicine
3400 Civic Center Boulevard
South Pavilion
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Education:
MS (Chemistry)
University of Pennsylvania, 2002.
BA (Chemistry)
University of Pennsylvania, 2002.
PhD (Biochemistry)
Washington University in St. Louis School of Medicine, 2009.
MD
Washington University in St. Louis School of Medicine, 2009.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Hereditary gastrointestinal cancer and polyposis syndromes. Gastrointestinal cancer risk evaluation.

Description of Research Expertise

Hereditary gastrointestinal cancer and polyposis syndromes. Cellular signaling and epigenetic mechanisms of tumorigenesis in colon cancer and gastroenteropancreatic neuroendocrine tumors.

Selected Publications

Stanich PP, Katona BW.: Rebranding Colonic Polyposis of Unknown Etiology: The Dawn of Idiopathic Adenomatous Polyposis. J Clin Gastroenterol 58: 107-108, Feb 2024.

Buckley KH, Beyries KA, Ryeom S, Yoon SS, Katona BW.: Establishment and Characterization of Patient-derived Gastric Organoids from Biopsies of Benign Gastric Body and Antral Epithelium. J Vis Exp (203, Jan 2024.

1. Levy S., Cappadocia J., Anantharajah A., Apostolico T., Ebrahimzadeh J., Clark D.F., Heller M., Mann D., McKenna D., Mercado J., Powers J., Ross A., Spielman K., Wineland D., Valverde K., Long J.M., Katona B.W.: Patient preferences for selective exclusion of high-risk genes on multigene panel testing. Podium presentation at the Pennsylvania Association of Genetic Counselors Annual Spring Meeting, Pittsburgh, PA 2024.

Buckley K.H., Dungan M.E., Dinh K., Bennett K.E., Beyries K.A., Majer A.D., Niccum B.A., Karakasheva T.A., Hamilton K.E., Kochman M.L., Ginsberg G.G., Ahmad N., Katona B.W.: Gastric epithelium and patient-derived gastric organoids from BRCA1/2 carriers harbor increased proliferation and DNA damage. Poster presentation at Digestive Disease Week, Washington, DC 2024.

Mirda D., Dungan M., Ren Y., Li H., Katona B.W.: Factors associated with adherence to colonic surveillance recommendations in Lynch syndrome. Poster presentation at Digestive Disease Week, Washington, DC 2024.

Pulaski M, Dungan M, Weber M, Constantino G, Katona BW.: Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome. Fam Cancer 2024.

Mirda D., Dungan M., Ren Y., Li H., Katona B.W.: Colorectal neoplasia detection rates in Lynch syndrome. Oral presentation at Digestive Disease Week, Washington, DC 2024.

Katona BW, Stadler ZK.: Less is more: rethinking colorectal cancer resection strategies in Lynch syndrome. Lancet Gastroenterol Hepatol 8(12): 1061-1063, Dec 2023.

Anez-Bruzual I, Coughlin S, Clay D, Heiman J, Dungan M, Weber M, Almario CV, Leung G, Ahmad NA, Ginsberg GG, Kochman ML, Valverde KD, Long JM, Katona BW.: Assessment of the Psychosocial Impact of Pancreatic Cancer Surveillance in High-Risk Individuals. Cancers (Basel) 16: 86, Dec 2023.

Lee H, Kipnis ST, Niman R, O'Brien SR, Eads JR, Katona BW, Pryma DA.: Prediction of (177)Lu-DOTATATE Therapy Outcomes in Neuroendocrine Tumor Patients Using Semi-Automatic Tumor Delineation on (68)Ga-DOTATATE PET/CT. Cancers (Basel) 16: 200, Dec 2023.

back to top
Last updated: 03/20/2024
The Trustees of the University of Pennsylvania